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Introduction of the 6-methyl substituent at the 6-position was affected by epoxidation of one of the early intermediates from diosgenin route, pregnenolone with alkaline hydrogen peroxide [2] . Petrow and his collaborators [3] have described several schemes that go back to diosgenin as the starting material. They reported a method for converting diosgenin into 3/?-acetoxy-6-methyl-25D-spirost-5-ene via (i) the 5a,6a-epoxide (ii) the 6/?-hydroxy-3,5-cyclo-25D-spirost-5-ene. Petrow also reported [4] the transformation of diosgenin to 6-methyl-25D-spirosta-3,6-diene-3-one employing the 3ß-acetoxy-5a-hydroxy-25D-spirostan-6-one as starting material. He obtained the 6-keto by first epoxidation of diosgenin followed by treatment of the epoxide by periodic acid in aqueous acetone and then oxidation of the triol.
In the present work we were seaking a more convenient method for preparation of the 5 a- hydroxy-6-ketone derivative of diosgenin (1 c) which is important as a starting material for synthesis of the 6-methyl-6,7-dehydro progesterone [4] . Fieser et al. reported [5] that oxidation of cholesterol with N-bromosuccinimide and acetic acid in aqueous acetone afforded 5a-cholestane-3/?,5-diol-6-one (2 c) in a moderate yield. We thought to extend this reaction to diosgenin hoping thereby to develop a convenient route for the preparation of the desired 5a-hydroxy-6-keto derivative. When we used NBS for the oxidation of diosgenin under the same conditions reported by Fieser [5] , we obtained a triol (la), C27H44O5, m.p. 281-283 °C. Its structure was established on the bases of spectral data (IR and MS) and by chemical conversion to 5a-25D-spirostane-3 /?,5-diol-6-one (1 c) with NBS in aqueous dioxane which is known to be specific for oxidation of 6 ^-hydroxy steroids [6] . Another proof for the triol structure (la) was arrived at by its oxidation with Jone's reagent [7] to the diketo derivative, 5a,25D-spirostane-5-ol-3,6-dione (le). This accounts for the presence of the two secondary hydroxyl groups at C-3 and C-6 positions. The tertiary hydroxyl group attached to C-5 was eliminated in a dehydration process when the diketonic derivative (le) was shaken in methanol containing 15% aqueous potassium hydroxide for 4 h at room temperature and 25D-spirost-4-ene-3,6-dione (If) was obtained as shown from its UV spectrum. From the foregoing data, it is clear that diosgenin when treated with NBS in a solvent mixture of acetone, water and acetic acid (8:1:0.1), the 5:6-double bond is oxidised to a trans glycollic system, 6ct,6/?-diol.
The generality of the above mentioned method as a new way for trans hydroxylation of zl 5 bond in steroids was demonstrated by its application for the preparation of 5a-cholestane-3/?,5,6/?-triol (2a), 5a-stigmastane-3ß,5,6ß-triol (3a) and 5a-androstane-3/?,5,6/?-triol-17-one (4a) from cholesterol, stigmasterol and dehydroisoandrosterone, respectively. The structures of all the formed triols were proved by their transformation to the corresponding 4-en-3,6-dione products.
As a result of this work, two new compounds were prepared and reported here for the first time which are 5a.25D-spirostane-5-ol-3,6-dione (le) and 5a-stigmastane-3/3,5-diol-6-one (3c). Similar results were reported by Ueno [8] and Morita [9] who independently found that oxidation of cholesterol by N,N-dibromobenzene sulfonamide and isocyanor bromide gave 5a-cholestane-3 ß,5,6ß-triol.
Experimental
Melting points were determined using a Büch 510 apparatus. IR spectra were recorded using Beckmann spectrophotometer 4220. Mass spectral data were obtained with mass spectrophotometer MAT 112. Ultraviolet spectra were recorded on CE 595 double beam digital ultraviolet spectrophotometer.
5a,25D-Spirostane-3ß,5,6ß-triol
(1 a) A suspension of diosgenin (1), (5 g, 0.012 mole) in acetone (200 ml) and water (25 ml) was treated with NBS (2.68 g, 0.15 mole, 1.25equiv) and acetic acid (2.5 ml) and was shaken occasionally at room temp. In the course of 45 min the mixture became yellow then orange and finally colorless where all the solid material disappeared in the solution. The reaction mixture was left overnight, diluted with water, extracted with ether and processed as usual to give an amorphous solid (5.6 g, 65% yield). Crystallisation from MeOH gave product la as shiny colorless plates, m.p. 282 to 284 °C. Reported [10] 
5a,25D-Spirostane-5-ol-3,6-dione
(le) A solution of compound 1 a (0.5 g, 0.0011 mole) in pure acetone (100ml) was cooled to 0 °C, treated with 2.3 ml of Jone's reagent [7] and processed as usual to give the dione material (le) in 96% yield (0.48 g). Crystallization from CHCl3/MeOH gave colourless needles, m.p. 270-272 °C. IR 4 B x r cm" 1 : 3950 (broad, OH), 1710 (C=0), 970, 920, 890 and 865 (spirostane side-chain).
Analysis: C27H40O5 Calcd C 72.97 H 9.00, Found C 77.21 H 9.24.
25D-Spirost-4-en-3,6-dione (If)
To the dione product (le) (0.5 g, 0.0011 mole) in MeOH (150 ml), was added KOH (7.5 ml from 15% aqueous solution) and the reaction mixture w as left on a shaker for 4 h. After concentrating under vacuum (to 50 ml) water was added and the precipitated material was filtered off, where a yellowish white solid (0.45 g, 90% yield) was ob- 
5a-Cholestane-3ß,5,6ß-triol (2 a)
It was prepared in the same manner as with the triol (la) in 80% yield, m.p. 235-237 °C (from acetone), reported [13] 
5a-Cholestane-3ß,5-diol-6-one (2 c)
It was prepared from the triol (2a) in 95% yield, m.p. 236-238 °C (from acetone), reported [5] m.p, 231 °C.IRv££cm-i: 3400 (OH) and 1710 (>C=0.) MS: mje\ 418 (M+, C27H46O3).
5a-Cholestane-3ß,5-diol-6-one-3-acetate (2d)
This derivative was obtained from product 2 c by mild acetylation in 80% yield, m.p. 233-235 °C (from acetate), reported [5] 
Cholest-4-ene-3,6-dione (2f)
Dehydration of compound 2 e gave product 2 f in 90% yield, m.p. 118-119 °C. Reported [15] 
5a-Stigmastane-3ß,5-diol-6-one-3-acetate (3d)
It was prepared in 80% yield by mild acetylation of product 3c, m.p. 243-247 °C (acetone). Reported [14] 
